TABLE 2:
Ablation Abutting Diaphragm | ||||
---|---|---|---|---|
Characteristic | Nondisplaced (n = 30) | Displaced (n = 25) | Control (n = 15) | p |
Tumor size (cm) | 2.5 ± 1.5 | 2.6 ± 1.2 | 2.5 ± 1.0 | 0.6 |
Distance from tumor to diaphragm (mm) | 4.9 ± 6.6 | 4.2 ± 6.0 | 41.5 ± 20.4 | < 0.001 |
Displacement distance (mm) | 0 | 5.6 ± 5.0 | 0 | < 0.001 |
Ablation zone size (cm) | 4.5 ± 1.3 | 4.1 ± 1.2 | 3.6 ± 0.8 | 0.1 |
Length of ablation zone abutting capsule (cm) | 3.7 ± 1.6 | 3.4 ± 1.2 | 0 | < 0.001 |
Ablation time (min) | 6.0 ± 2.7 | 7.2 ± 3.3 | 5.5 ± 2.5 | 0.2 |
Ablation power (W) | 70.8 ± 19.1 | 80.8 ± 23.7 | 79.3 ± 19.6 | 0.02 |
No. of diaphragmatic hernias | 0 | 0 | 0 | |
Diaphragm thickness preablation (mm) | 3.2 ± 1.2 | 3.0 ± 1.2 | 3.0 ± 0.5 | 0.5 |
Diaphragm thickness immediately postablation (mm) | 3.6 ± 1.3 | 4.4 ± 2.4 | 3.1 ± 0.5 | 0.3 |
Patients with shoulder pain, no. (%) | 5 (16.7) | 5 (20) | 0 (0) | 0.2 |
Average pain score | 3.1 ± 2.2 | 2.5 ± 1.8 | 2.4 ± 1.2 | 0.4 |
Initial pain score | 4.2 ± 3.0 | 2.7 ± 2.8 | 3.1 ± 2.2 | 0.1 |
Local tumor progression, no. (%) | 2 (6.7) | 1 (4) | 0 (0) | 1 |
Imaging follow-up (mo) | 10.6 ± 6.6 | 11.6 ± 9.4 | 14.1 ± 8.5 | 0.2 |
Note—Except where noted otherwise, data are mean ± SD. Peripheral liver lesions are subdivided according to whether peritoneal fluid displaced the diaphragm away from the liver capsule (displaced vs nondisplaced).